Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets Medical Dialogues Bureau10 April 2020 7:30 AM GMTHyderabad: Aurobindo Pharma Limited has announced that the Company has received the final approval from the US Food & Drug Administration (USFDA) t...
Aurobindo Pharma faces CA Suit in US for concealing facts Medical Dialogues Bureau9 April 2020 8:06 AM GMTHyderabad: A class-action suit has been filed against some drug manufacturers, including Aurobindo Pharma and Emcure Pharmaceuticals, in a USA court fo...
Aurobindo, Sandoz call off 900 million US dollar deal Medical Dialogues Bureau2 April 2020 9:57 AM GMTNew Delhi: Aurobindo Pharma on Thursday said the USD 900 million deal to acquire Sandoz Inc''s US-based generic oral solids and dermatology businesses,...
NPPA directs 3 pharma cos to maintain stock of atleast 2.2 crore tablets of FDC Lopinavir and Ritoavir Medical Dialogues Bureau29 March 2020 7:49 AM GMTNew Delhi: The National Pharmaceuticals Pricing Authority (NPPA), Department of Pharmaceuticals directed 3 major manufacturers of the HIV Combo...
Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal Medical Dialogues Bureau26 Nov 2019 4:00 AM GMTIn September 2018, the USD three billion drug-maker, Aurobindo Pharma said its US subsidiary entered into an agreement to acquire commercial operations...
Aurobindo Pharma gets 14 USFDA observations for Pashamylaram facility Farhat Nasim15 Nov 2019 6:43 AM GMTThe US Food and Drug Administration (USFDA) inspected company's Unit IV, a general injectable formulation manufacturing facility situated at Pashamylar...
Aurobindo Pharma Q2 net profit up by 5 pc to Rs 640 crore Medical Dialogues Bureau14 Nov 2019 4:00 AM GMTManaging director of Aurobindo Pharma N Govindarajan said We had another quarter of healthy performance where we continued to grow in the US and Europe...
Aurobindo Pharma USA recalls heartburn drug Ranitidine over cancer causing impurities Medical Dialogues Bureau10 Nov 2019 4:15 AM GMTAurobindo Pharma is second city-based drug company that has initiated the voluntary recall after the FDA announced an investigation into the reported c...
Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA Medical Dialogues Bureau11 Oct 2019 4:30 AM GMT'The responsibilities and procedures applicable to the quality control unit are not fully followed. Several lists of documents requested were either pr...
Aurobindo Pharma Unit-7 gets 7 USFDA observations Medical Dialogues Bureau8 Oct 2019 9:24 AM GMTThe United States Food and Drug Administration (USFDA) conducted a Current Good Manufacturing Practices (CGMP) inspection at the company's unit-7 manuf...
Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over Medical Dialogues Bureau23 Sep 2019 4:30 AM GMTRanitidine is an Over-The-Counter (OTC) and prescription drug which decreases the amount of acid created by the stomach.Hyderabad: Dr Reddy's...
CDSCO releases updated list of 2006 WHO GMP certified drug manufacturers; Details Farhat Nasim6 Jun 2019 6:41 AM GMTNew Delhi: The apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has recently released an updated list of WHO GMP...
